Abacus Life, Inc. (NASDAQ:ABL) Receives $14.08 Average PT from Analysts
Shares of Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target […]
Shares of Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target […]
